SCHEMBL808761

SCHEMBL808761

CCCCC=CCOC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
F7 P08709 2/20 0.47
F3 P13726 2/20 0.47
PRKCA P17252 1/20 0.44
FAAH O00519 5/20 0.43
TERT O14746 3/20 0.42
PTPN1 P18031 3/20 0.42
PPARG P37231 3/20 0.42
PPARD Q03181 3/20 0.42
PPARA Q07869 3/20 0.42
CYP1A2 P05177 2/20 0.42
MAPT P10636 2/20 0.42
CYP2C19 P33261 2/20 0.42
BLM P54132 2/20 0.42
HSD17B10 Q99714 2/20 0.42
FABP4 P15090 2/20 0.42
KMT2A Q03164 2/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15237135 1.00 ALDH1A1 (0.50) ALDH1A1F7F3PRKCAFAAH
SCHEMBL808759 1.00 ALDH1A1 (0.50) ALDH1A1F7F3PRKCAFAAH
SCHEMBL1898702 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL31019571 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL31084293 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL1301154 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL434985 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL6479269 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL592739 0.96 F7 (0.53) F7F3PRKCAFAAHTERT
SCHEMBL1301724 0.96 F7 (0.53) F7F3PRKCAFAAHTERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395534-B1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS MATERIA INC (US) 2017-08-30 EP claimed
US-6900347-B2 Impurity inhibition in olefin metathesis reactions TILLIECHEM, INC. (US) 2005-05-31 US claimed
EP-1395534-A1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS Pederson, Richard L. (US) 2004-03-10 EP claimed
US-20030023123-A1 Impurity inhibition in olefin metathesis reactions MATERIA, INC. 2003-01-30 US claimed
WO-2002094748-A1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS PEDERSON RICHARD L (US) 2002-11-28 WO claimed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
EP-3880163-A1 USE OF 1-ETHYL-4,4-DIMETHYL-CYCLOHEXANE DERIVATIVES AS FRAGRANCES Symrise AG (DE) 2021-09-22 EP disclosed
CN-112969444-A Use of 1-ethyl-4, 4-dimethylcyclohexane derivatives as fragrance substances 西姆莱斯有限公司 2021-06-15 CN disclosed
EP-3601508-A1 5-BICYCLO[2.2.1]HEPT-2-ENYL-ACETATE AS A SCENTING AND/OR FLAVORING AGENT Symrise AG (DE) 2020-02-05 EP disclosed
US-9869027-B2 Cleaning composition and method of manufacturing metal wiring using the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
EP-1395534-B1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS MATERIA INC (US) 2017-08-30 EP disclosed
US-20160230289-A1 CLEANING COMPOSITION AND METHOD OF MANUFACTURING METAL WIRING USING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2016-08-11 US disclosed
US-20050143599-A1 Process for preparing monoesters 3M INNOVATIVE PROPERTIES COMPANY 2005-06-30 US disclosed
US-6900347-B2 Impurity inhibition in olefin metathesis reactions TILLIECHEM, INC. (US) 2005-05-31 US disclosed
US-6838576-B1 Process for preparing functional group-containing olefinic compounds 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-01-04 US disclosed
EP-1395534-A1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS Pederson, Richard L. (US) 2004-03-10 EP disclosed
US-20030023123-A1 Impurity inhibition in olefin metathesis reactions MATERIA, INC. 2003-01-30 US disclosed
WO-2002094748-A1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS PEDERSON RICHARD L (US) 2002-11-28 WO disclosed
US-3984478-A TREATING AN UNSATURATED COMPOUND WITH CARBON MONOXIDE IN A HETEROGENEOUS CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-10-05 US disclosed
US-3949007-A METAL HYDROXIDE OR ALKOXIDE CATALYST BAYER AKTIENGESELLSCHAFT (DT) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030023123-A1 Impurity inhibition in olefin metathesis reactions CYP51A1, CYP1B1, SQLE ALDH1A1 513/4885F7 2395/4885F3 500/4885
US-20050143599-A1 Process for preparing monoesters ADSL, COASY, AGPS ALDH1A1 217/4885F7 928/4885F3 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.